FIELD: medicine.
SUBSTANCE: invention relates to field of medicine, namely to infectious diseases and hepatology. In order to carry out differential diagnostics of hepatic fibrosis in case of chronic viral hepatitic C patient's venous blood is analysed. Concentration of transforming growth factor -1β (TGF-1β) in blood serum is determined by method of solid-phase ELISA. If value of TGF-1β concentration is higher than 400 pg/ml, mild or moderate hepatic fibrosis is diagnosed. If TGF-1β value is lower than 400 pg/ml, severe fibrosis or hepatocirrhosis is diagnosed.
EFFECT: method is non-invasive, is characterised by high accuracy of differential diagnostics of hepatic fibrosis in case of chronic viral hepatitis C.
2 dwg, 6 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2709507C1 |
| METHOD FOR LABORATORY DIAGNOSIS OF STAGES OF HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIS C | 2015 |
|
RU2583939C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC FIBROSIS ACCOMPANYING VIRAL HEPATITIS C | 2014 |
|
RU2557927C1 |
| METHOD FOR DIAGNOSTICS OF SEVERE LIVER FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C WITH GENOTYPE 1 | 2017 |
|
RU2639480C1 |
| METHOD OF DIFFERENTIATING HEPATIC FIBROSIS IN CHRONIC VIRAL HEPATITIS B AND AUTOIMMUNE LIVER INJURIES | 2018 |
|
RU2701723C1 |
| DIAGNOSTIC TECHNIQUE FOR HEPATIC CIRRHOSIS (STAGE F4) IN THE OUTCOME OF CHRONIC VIRAL HEPATITIS C | 2019 |
|
RU2724595C1 |
| METHOD OF HEPATIC FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC VIRAL HEPATITIS TYPE C | 2009 |
|
RU2416794C1 |
| TECHNIQUE FOR DIAGNOSTICS OF HEPATIC FIBROSIS STAGES IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2015 |
|
RU2592371C1 |
| METHOD FOR DIAGNOSING THE STAGE OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC VIRAL HEPATITIS B | 2019 |
|
RU2697054C1 |
| DIAGNOSTIC TECHNIQUE FOR CIRRHOTIC STAGE OF CHRONIC VIRAL HEPATITIS C | 2014 |
|
RU2563129C1 |
